We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
870
Increased
2,213
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.38%
2 Healthcare 7.46%
3 Consumer Discretionary 5.14%
4 Industrials 5.11%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCFA.WS
5501
CALL
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$31.2K ﹤0.01%
260,000
ACRO.WS
5502
CALL
DELISTED
Acropolis Infrastructure Acquisition Corp Warrants
ACRO.WS
$31.1K ﹤0.01%
357,430
NETC.WS
5503
CALL
DELISTED
Nabors Energy Transition Corp. Warrants, exercisable for one share of Class A Common Stock
NETC.WS
$31K ﹤0.01%
194,000
DISAW
5504
CALL
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$30.7K ﹤0.01%
334,131
NKTX icon
5505
Nkarta
NKTX
$194M
$30.5K ﹤0.01%
13,943
-58
-0.4% -$255
NFYS.WS
5506
CALL
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
$30K ﹤0.01%
600,000
BGMS
5507
Bio Green Med Solution Inc
BGMS
$5.81M
$29.8K ﹤0.01%
14
-19
-58% -$42.4K
FRBNW
5508
CALL
DELISTED
Forbion European Acquisition Corp. Warrants
FRBNW
$29.7K ﹤0.01%
69,000
DCX
5509
Digital Currency X Technology Inc
DCX
$344M
0
TMQ
5510
Trilogy Metals
TMQ
$663M
$29.1K ﹤0.01%
48,982
-474,751
-91% -$268K
CMPOW
5511
CALL
DELISTED
CompoSecure Inc Warrant
CMPOW
$28.9K ﹤0.01%
27,500
KRRO icon
5512
Korro Bio
KRRO
$202M
$28.8K ﹤0.01%
1,666
+681
+69% +$13.2K
BIOL
5513
DELISTED
Biolase, Inc.
BIOL
$28.8K ﹤0.01%
+4,068
New +$68.1K
BSAQ.WS
5514
CALL
DELISTED
Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BSAQ.WS
$28.7K ﹤0.01%
183,850
PLMJW
5515
CALL
DELISTED
Plum Acquisition Corp. III Warrant
PLMJW
$28.1K ﹤0.01%
678,496
MNPR icon
5516
Monopar Therapeutics
MNPR
$744M
$28K ﹤0.01%
+6,552
New +$33.5K
CANO
5517
CALL
DELISTED
Cano Health, Inc.
CANO
$27.8K ﹤0.01%
200
-5,000
-96% -$642K
MBOT icon
5518
Microbot Medical
MBOT
$101M
$27.8K ﹤0.01%
10,219
-4,643
-31% -$9.3K
ASBPW
5519
CALL
Aspire Biopharma Warrant
ASBPW
$369K
$27.6K ﹤0.01%
550,000
GURE
5520
Gulf Resources
GURE
$6.15M
$27.1K ﹤0.01%
1,091
-2,689
-71% -$74.4K
APGB.WS
5521
CALL
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$26.6K ﹤0.01%
217,314
+23,374
+12% +$3.02K
FRXB.WS
5522
CALL
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$26.4K ﹤0.01%
175,850
-29,000
-14% -$4.6K
BWAY
5523
Brainsway
BWAY
$580M
$26.1K ﹤0.01%
+22,998
New +$20.6K
KCGI.WS
5524
CALL
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
$26.1K ﹤0.01%
327,759
CANO.WS
5525
CALL
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$25.8K ﹤0.01%
122,909

Similar funds

Israel Englander's Q2 2023 Portfolio in Review

As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
  • Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.